Cite
Bowers C, Mytych DT, Lawrence T, et al. Assessment of romiplostim immunogenicity in pediatric patients in clinical trials and in a global postmarketing registry. Blood Adv. 2021;5(23):4969-4979doi: 10.1182/bloodadvances.2021005105.
Bowers, C., Mytych, D. T., Lawrence, T., Wang, K., Barger, T. E., Eisen, M., Bennett, C. M., & Tarantino, M. D. (2021). Assessment of romiplostim immunogenicity in pediatric patients in clinical trials and in a global postmarketing registry. Blood advances, 5(23), 4969-4979. https://doi.org/10.1182/bloodadvances.2021005105
Bowers, Charles, et al. "Assessment of romiplostim immunogenicity in pediatric patients in clinical trials and in a global postmarketing registry." Blood advances vol. 5,23 (2021): 4969-4979. doi: https://doi.org/10.1182/bloodadvances.2021005105
Bowers C, Mytych DT, Lawrence T, Wang K, Barger TE, Eisen M, Bennett CM, Tarantino MD. Assessment of romiplostim immunogenicity in pediatric patients in clinical trials and in a global postmarketing registry. Blood Adv. 2021 Dec 14;5(23):4969-4979. doi: 10.1182/bloodadvances.2021005105. PMID: 34638135.
Copy
Download .nbib